Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion

被引:62
作者
Barber, DF
Bartolomé, A
Hernandez, C
Flores, JM
Fernandez-Arias, C
Rodríguez-Borlado, L
Hirsch, E
Wymann, M
Balomenos, D
Carrera, AC
机构
[1] Univ Autonoma Madrid, Dept Immunol & Oncol, E-28049 Madrid, Spain
[2] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Anim Facil, E-28049 Madrid, Spain
[3] Univ Complutense Madrid, Sch Vet, Dept Anim Med & Surg, E-28040 Madrid, Spain
[4] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[5] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
关键词
D O I
10.4049/jimmunol.176.1.589
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I PI3K catalyzes formation of 3-poly-phosphoinositides. The family is divided into I-A isoforms, activated by Tyr kinases and I-A the I-B isoform (PI3K gamma), activated by G protein-coupled receptors. Mutations that affect PI3K are implicated in chronic inflammation, although the differential contribution of each isoform to pathology has not been elucidated. Enhanced activation of class I-A-PI3K in T cells extends CD4(+) memory cell survival, triggering an invasive lymphoproliferative disorder and systemic lupus. As both I-A- and 1(B)-PI3K isoforms regulate T cell activation, and activated pathogenic CD4(+) memory cells are involved in triggering systemic lupus, we examined whether deletion of I-B could reduce the pathological consequences of increased I-A-PI3K activity. I-B-PI3K gamma deficiency did not abolish invasion or lymphoproliferation, but reduced CD4(+) memory cell survival, autoantibody production, glomerulonephritis, and systemic lupus. Deletion of the I-B-PI3K gamma isoform thus decreased survival of pathogenic CD4(+) memory cells, selectively inhibiting systemic lupus development. These results validate the PI3K gamma isoform as a target for systemic lupus erythernatosus treatment.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 24 条
  • [1] PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
    Barber, DF
    Bartolomé, A
    Hernandez, C
    Flores, JM
    Redondo, C
    Fernandez-Arias, C
    Camps, M
    Ruckle, T
    Schwarz, MK
    Rodríguez, S
    Martinez-A, C
    Balomenos, D
    Rommel, C
    Carrera, AC
    [J]. NATURE MEDICINE, 2005, 11 (09) : 933 - 935
  • [2] BERDEN JHM, 1983, J IMMUNOL, V130, P1699
  • [3] Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase
    Bi, L
    Okabe, I
    Bernard, DJ
    Wynshaw-Boris, A
    Nussbaum, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) : 10963 - 10968
  • [4] Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
    Bi, L
    Okabe, I
    Bernard, DJ
    Nussbaum, RL
    [J]. MAMMALIAN GENOME, 2002, 13 (03) : 169 - 172
  • [5] Borlado LR, 2000, FASEB J, V14, P895
  • [6] New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway
    Cantley, LC
    Neel, BG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) : 4240 - 4245
  • [7] Impaired Fas response and autoimmunity in Pten+/- mice
    Di Cristofano, A
    Kotsi, P
    Peng, YF
    Cordon-Cardo, C
    Elkon, KB
    Pandolfi, PP
    [J]. SCIENCE, 1999, 285 (5436) : 2122 - 2125
  • [8] Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling
    Fruman, DA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) : 314 - 320
  • [9] Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
    Hirsch, E
    Katanaev, VL
    Garlanda, C
    Azzolino, O
    Pirola, L
    Silengo, L
    Sozzani, S
    Mantovani, A
    Altruda, F
    Wymann, MP
    [J]. SCIENCE, 2000, 287 (5455) : 1049 - 1053
  • [10] KLINMAN DM, 1995, IMMUNOL REV, V144, P157